Grade 1 Meningioma — Trials

Grade 1 Meningioma — Trials · CancerIndex

Clinical trials

Registered studies

20 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01125046	Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas	completed	Phase 2	50	Northwestern UniversityOTHER	1	Jan 22, 2021	clinicaltrials
NCT00045110	Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma	completed	Phase 1 / Phase 2	136	National Cancer Institute (NCI)NIH	1	Aug 17, 2017	clinicaltrials
NCT00045734	Imatinib Mesylate in Treating Patients With Recurrent Meningioma	completed	Phase 2	23	National Cancer Institute (NCI)NIH	1	May 15, 2017	clinicaltrials
NCT00004078	Irinotecan in Treating Children With Refractory Solid Tumors

Data updated 22 days agoSource updated Jan 22, 2021source: clinicaltrials